Conversely, LDL-c, ApoB, LDLox, and LDLox/ApoB, decreased in the Stilvid® group, the ratio of non-HDL-c (total atherosclerotic cholesterol load)/ApoB increased, confirming that resveratrol reduced atherosclerosis markers and may have other cardioprotective effects beyond the gold standard drugs (Tomé-Carneiro et al., 2012). This evidence concerns the gene APOB and atherosclerosis.